Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,572,983
+$344,660 QoQ
Shares Held
18,006
+4.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#1,686
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornerstone Advisory, LLC holds $14,912,700 across 7 Drug Manufacturers - General names. JNJ ranks #1 (30.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
18,006 | $4,572,983 | |
| 2 | ABBV |
AbbVie Inc.
|
16,202 | $4,077,071 | |
| 3 | LLY |
ELI LILLY & Co
|
2,851 | $3,419,575 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,923 | $1,403,605 | |
| 5 | AMGN |
Amgen Inc
|
2,073 | $750,674 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,585 | $379,427 | |
| 7 | NVS |
Novartis AG
|
1,974 | $309,365 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,572,983 | 18,006 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,228,323 | 17,298 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,555,607 | 17,181 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $3,344,049 | 18,035 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,643,797 | 17,308 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,865,715 | 17,280 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,454,346 | 16,971 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $2,755,991 | 17,006 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,503,574 | 17,129 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,830,019 | 17,890 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,916,461 | 18,607 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,907,696 | 18,669 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,243,033 | 19,593 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $3,157,505 | 20,371 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,942,282 | 16,656 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,038,169 | 18,598 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $2,932,642 | 16,521 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,706,519 | 26,556 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $4,377,509 | 25,589 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $4,112,920 | 25,467 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,084,068 | 24,791 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,582,734 | 27,884 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,417,184 | 28,067 | Shares | Sole | 2021-05-11 | |
| 2020-09-30 | $3,951,274 | 26,540 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,649,347 | 25,950 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,197,345 | 16,757 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||